| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-08-1474 |
| P698 | PubMed publication ID | 19088032 |
| P50 | author | Hidde J. Haisma | Q37830344 |
| P2093 | author name string | Sabine Ring | |
| Roland E Kontermann | |||
| Alexander H Enk | |||
| Karsten Mahnke | |||
| Theron S Johnson | |||
| Kurt Schönfeld | |||
| Dirk M Nettelbeck | |||
| Fabrice Le Gall | |||
| Volker Storn | |||
| P433 | issue | 24 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 8169-8177 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule | |
| P478 | volume | 14 |
| Q37079131 | A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice. |
| Q30369012 | A novel method for synthetic vaccine construction based on protein assembly |
| Q87395602 | A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles |
| Q38921652 | Advances and challenges: dendritic cell vaccination strategies for glioblastoma. |
| Q34341859 | Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity |
| Q33870736 | Aptamer-targeted antigen delivery |
| Q42044252 | Bioinformatics-led design of single-chain antibody molecules targeting DNA sequences for retinoblastoma |
| Q47572384 | CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals. |
| Q90161713 | Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting |
| Q41580130 | Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. |
| Q26777948 | Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses |
| Q39787210 | HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC. |
| Q96434459 | Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1-specific CD8+ T cells |
| Q42106951 | Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors. |
| Q39424337 | Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas |
| Q37683966 | Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver. |
| Q39448911 | Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines |
| Q35928270 | Targeting Dendritic Cells in vivo for Cancer Therapy |
| Q40254340 | Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice |
| Q91999288 | The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells |
| Q34513833 | The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells |
| Q26773073 | Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines |
Search more.